UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

EBioMedicine, 2018-03, Vol.29, p.23-30

2018

Volltextzugriff (PDF)

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status

Molecular diagnosis & therapy, 2014-12, Vol.18 (6), p.605-617

2014

Volltextzugriff (PDF)

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

Frontiers in immunology, 2022-08, Vol.13, p.926318-926318

2022

Volltextzugriff (PDF)

Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis

Journal of the neurological sciences, 2012-02, Vol.313 (1), p.167-177

2012

Volltextzugriff (PDF)

Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect

Biology open, 2023-03, Vol.12 (3)

2023

Volltextzugriff (PDF)

Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study

Frontiers in immunology, 2023-06, Vol.14, p.1194671-1194671

2023

Volltextzugriff (PDF)

Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

Stem cell research & therapy, 2024-05, Vol.15 (1), p.151-14, Article 151

2024

Volltextzugriff (PDF)

Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response

PloS one, 2017-04, Vol.12 (4), p.e0175575-e0175575

2017

Volltextzugriff (PDF)

Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice

Experimental neurology, 2014-11, Vol.261, p.620-632

2014

Volltextzugriff (PDF)

Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine‐induced blood brain barrier dysfunction via suppression of MLCK signaling pathway

Immunity, Inflammation and Disease, 2018-03, Vol.6 (1), p.72-80

2018

Volltextzugriff (PDF)

Safety of long-term intrathecal methotrexate in progressive forms of MS

Therapeutic advances in neurological disorders, 2019, Vol.12, p.1756286419892360-1756286419892360

2019

Volltextzugriff (PDF)

Stem cells in amyotrophic lateral sclerosis: Hype or hope?

Neurology, 2019-12, Vol.93 (24), p.1028-1029

2019

Volltextzugriff (PDF)

Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

Neurobiology of disease, 2010-10, Vol.40 (1), p.331-339

2010

Volltextzugriff (PDF)

Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome

Archives of physical medicine and rehabilitation, 2002-06, Vol.83 (6), p.735-741

2002

Volltextzugriff (PDF)

Clinical safety of intrathecal administration of mesenchymal stromal cell–derived neural progenitors in multiple sclerosis

Cytotherapy (Oxford, England), 2016-12, Vol.18 (12), p.1476-1482

2016

Volltextzugriff (PDF)

Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis

PloS one, 2023-08, Vol.18 (8), p.e0290069-e0290069

2023

Volltextzugriff (PDF)

Mesenchymal stem cell-derived neural progenitors attenuate proinflammatory microglial activation via paracrine mechanisms

Regenerative medicine, 2023-03, Vol.18 (3), p.259-273

2023

Volltextzugriff (PDF)

Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes

Multiple sclerosis, 2017-11, Vol.23 (13), p.1707-1715

2017

Volltextzugriff (PDF)

Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic

Brain (London, England : 1878), 2023-05, Vol.146 (5), p.1979-1992

2023

Volltextzugriff (PDF)

Biomarkers of multiple sclerosis: current findings

Degenerative Neurological and Neuromuscular Disease, 2017-01, Vol.7, p.19-29

2017

Volltextzugriff (PDF)

Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

Multiple sclerosis, 2013-10, Vol.19 (11), p.1462-1472

2013

Volltextzugriff (PDF)

Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice

Frontiers in molecular neuroscience, 2013-01, Vol.6, p.34-34

2013

Volltextzugriff (PDF)

Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study

Neurology : neuroimmunology & neuroinflammation, 2021-01, Vol.8 (1)

2021

Volltextzugriff (PDF)

Characterization of Autologous Mesenchymal Stem Cell‐Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis

Stem cells translational medicine, 2012-07, Vol.1 (7), p.536-547

2012

Volltextzugriff (PDF)

Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice

Stem cells and development, 2011-12, Vol.20 (12), p.2065-2076

2011

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(171)
Buchkapitel
(1)

Sprache

Englisch
(172)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis

Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect

Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study

Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response

Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice

Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine‐induced blood brain barrier dysfunction via suppression of MLCK signaling pathway

Safety of long-term intrathecal methotrexate in progressive forms of MS

Stem cells in amyotrophic lateral sclerosis: Hype or hope?

Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome

Clinical safety of intrathecal administration of mesenchymal stromal cell–derived neural progenitors in multiple sclerosis

Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis

Mesenchymal stem cell-derived neural progenitors attenuate proinflammatory microglial activation via paracrine mechanisms

Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes

Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic

Biomarkers of multiple sclerosis: current findings

Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice

Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study

Characterization of Autologous Mesenchymal Stem Cell‐Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis

Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice

Suchergebnisse filtern